Welcome to our dedicated page for Kneat Com news (Ticker: KSIOF), a resource for investors and traders seeking the latest updates and insights on Kneat Com stock.
KNEAT COM INC (OTCQX: KSIOF), also known as Kneat, regularly issues news updates that highlight its role in digitizing and automating validation and quality processes for highly regulated industries. Company announcements frequently cover new Master Services Agreements with global organizations in life sciences, healthcare technology, specialty chemicals, equipment manufacturing and related sectors, reflecting how its Kneat Gx platform is adopted across large, multi-site operations.
Investors and industry professionals following KSIOF news will see recurring themes around enterprise-scale deployments of Kneat Gx for computer systems validation, equipment validation, commissioning, qualification and validation (CQV), electronic logbooks, equipment testing workflows and drawing management processes. Many releases describe customers with operations in dozens of countries and thousands of employees, underscoring the platform’s use in complex, global environments.
Kneat’s news flow also includes financial results updates, where the company reports on total revenue, SaaS revenue, gross margin, and Annual Recurring Revenue (ARR), along with non‑IFRS metrics such as EBITDA and Adjusted EBITDA. These releases often discuss trends in new customer additions, expansions with existing customers and the company’s focus on scaling its SaaS business model.
Additional announcements highlight product evolution and AI capabilities, such as new versions of Kneat Gx that enhance data management, traceability, and support for risk-based validation approaches. Kneat also reports on external recognition, including leadership positions in G2 Pharma and Biotech software grids based on user satisfaction and market presence, and on events like its VALIDATE conference and investor presentations.
For readers interested in how digital validation and quality process automation are being adopted across life sciences and other regulated sectors, the KSIOF news page provides an ongoing view of Kneat’s customer wins, platform enhancements and financial performance.
Kneat has signed a three-year Master Services Agreement with ALTEN SA, a global Engineering and IT Services company. ALTEN will use Kneat Gx to digitize validation processes for itself and its Life Sciences customers. With nearly 60,000 employees across 30+ countries, ALTEN serves pharmaceutical, biotechnology, medical device, and related industries. The implementation will begin with Commissioning and Qualification processes, aiming to improve efficiency and data integrity in validation workflows.
Kneat reported strong Q3 2024 financial results with total revenue reaching $12.8 million, up 52% year-over-year. The company achieved significant growth in key metrics, including a 78% increase in gross profit to $9.8 million and improved gross margin of 77%. SaaS revenue grew 48% to $11.5 million, while Annual Recurring Revenue (ARR) increased 59% to $49.9 million. The company reported positive net income of $1.2 million compared to a loss of $3.6 million in Q3 2023. Additionally, Kneat completed a bought deal offering raising $35.6 million and secured new strategic customers in the pharmaceutical and medical devices sectors.
A global medical devices manufacturer has signed a three-year Master Services Agreement with Kneat to digitize its validation processes. The client, headquartered in Germany, employs over 11,000 people and operates 30+ production sites across 15 countries in Europe, Asia and the Americas. The company provides solutions to pharma, biotech and cosmetic industries, including pharmaceutical packaging, drug delivery systems, diagnostic devices, and digital healthcare solutions. They plan to implement the Kneat Gx platform for Commissioning, Qualification and Validation (CQV) processes.